Patents by Inventor Nicolas Gueritee

Nicolas Gueritee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pure 17 alpha-ethynyl(5 alpha), androst-2-ene,17 beta-cl, process for its preparation and therapeutical applications of the same
    Patent number: 4278668
    Abstract: The delta-2 isomer of the 17 alpha-ethynyl (5 alpha), 2-androsten, 17 beta-ol, unmixed with its delta-3 isomer; a process for making the therapeutic isomer and its 17 beta-acetate; and a method of treatment of endometriosis with the 17 beta-acetate of the delta-2 isomer. The pure delta-2 isomer of 17 alpha-ethynyl (5 alpha), 2-androsten, 17 beta-ol, unmixed with its delta-3 isomer, is obtained by oxidation of the isomeric precursor 17-keto (5 alpha), 2-androsten with Jones Reagent. The 17 beta-acetate of the delta-2 isomer of the beta-ol is effective in the treatment of endometriosis by the administration of a daily dose of about 100 to 300 milligrams.
    Type: Grant
    Filed: July 16, 1979
    Date of Patent: July 14, 1981
    Inventor: Nicolas Gueritee
  • Nicotinic derivatives of estriol
    Patent number: 4110324
    Abstract: Nicotinic estriol derivatives, having hypolipidemic activity, are described.
    Type: Grant
    Filed: October 29, 1976
    Date of Patent: August 29, 1978
    Inventor: Nicolas Gueritee
  • Nicotinic derivatives of estriol
    Patent number: 4042581
    Abstract: Nicotinic estriol derivatives, having hypolipidemic activity, are described.
    Type: Grant
    Filed: February 19, 1975
    Date of Patent: August 16, 1977
    Inventor: Nicolas Gueritee